Pages that link to "Q33839468"

The following pages link to Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles (Q33839468):

Displaying 24 items.

• Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression (Q33712891) (← links)
• Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates (Q33742529) (← links)
• Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection (Q34315612) (← links)
• Challenges in the design of a T cell vaccine in the context of HIV-1 diversity (Q34423446) (← links)
• Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques (Q34611170) (← links)
• Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals (Q34630184) (← links)
• Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control (Q35022846) (← links)
• Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses (Q35049821) (← links)
• Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses (Q35130519) (← links)
• Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals (Q35153129) (← links)
• Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges (Q35160124) (← links)
• CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types (Q35797743) (← links)
• Comprehensive analysis of unique cases with extraordinary control over HIV replication (Q36010191) (← links)
• HLA-C and HIV-1: friends or foes? (Q36066058) (← links)
• Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection (Q37187509) (← links)
• Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100 (Q37489634) (← links)
• HIV vaccines: progress to date. (Q37851950) (← links)
• HLA and pharmacogenetics of drug hypersensitivity. (Q38037649) (← links)
• Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer. (Q38089937) (← links)
• Success and failure of the cellular immune response against HIV-1. (Q38491191) (← links)
• Complex immune correlates of protection in HIV-1 vaccine efficacy trials (Q39108779) (← links)
• Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection. (Q40106524) (← links)
• Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis (Q89511647) (← links)
• Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer (Q91637388) (← links)